Copyright
©The Author(s) 2021.
World J Clin Cases. Aug 6, 2021; 9(22): 6218-6233
Published online Aug 6, 2021. doi: 10.12998/wjcc.v9.i22.6218
Published online Aug 6, 2021. doi: 10.12998/wjcc.v9.i22.6218
Phase | Exosome source | Nomenclature | Related exosomal cargo | Secreted factors or expressed genes affected | Outcome | Ref. |
Hemostasis Phase | Human mesenchymal stem cells (MSCs) from the umbilical cord | EVs | - | Phosphatidylserine(+) | Umbilical MSCs and extracellular vesicles derived from them have a reasonably high procoagulant potential | [42] |
Inflammatory Phase | Human jaw bone marrow-derived MSCs and bone marrow MSCs | Exosomes | miR-223 | TNF-α ↓ IL-10 ↑ | Accelerated wound healing in mice | [46] |
Induced M2 macrophage polarization (CD206+ macrophage ↑) | ||||||
Human umbilical cord (UC)-MSCs | Exosomes | let-7b | TLR4, p-p65, iNOS ↓ p-STAT3, p-AKT, ARG1 ↑ | Alleviated inflammation and enhanced diabetic cutaneous wound healing in rats | [47] | |
Induced M2 macrophage polarization Inhibited TLR4 signaling pathway | ||||||
Human UC-MSCs | Exosomes | miR-181c | TNF-α, IL-1β, TLR4, p65, p-p65↓ IL-10 ↑ | Reduced burn-induced inflammation in rats | [48] | |
Reduced neutrophil and macrophage infiltration (MPO+ cell,CD68+ cell↓) Inhibited TLR4 signaling pathway | ||||||
Human menstrual blood derived MSCs (MenSCs) | Exosomes | - | iNOS ↓ ARG1, VEGF ↑ | Resolved inflammation and ameliorate cutaneous non healing wounds in diabetic mice | [49] | |
Induced M2 macrophage polarization | ||||||
Proliferative Phase | Human bone marrow MSC-derived exosomes | Exosomes | TGF-β/Smad | TGF-β1, Smad2, Smad3, Smad4 ↓TGF-β3, Smad7↑ | Effectively promoted the cutaneous wound healing by inhibiting the TGF-β/Smad signal pathway | [59] |
Human adipose MSCs (ASCs) | Exosomes | - | N-cadherin, cyclin 1, PCNA, collagen I/III, elastin ↑ | Facilitated cutaneous wound healing via optimizing the characteristics of fibroblasts | [62] | |
Human ASCs | Exosomes | - | Collagen I/II, TGF-β1/3, MMP1/3 α-SMA ↓ | Promoted ECM reconstruction in cutaneous wound repair by regulating the ratios of collagen type III: type I, TGF-β3:TGF-β1, and MMP3:TIMP1, and by regulating fibroblast differentiation to mitigate scar formation | [63] | |
Human fetal dermal MSCs | Exosomes | Jagged 1 | Collagen I/III, elastin, fibronectin mRNA ↑ | Promoted wound healing by activating the ADF cell motility and secretion ability via the Notch signaling pathway | [64] | |
Human UC-MSCs | Exosomes | Wnt4 | CK19, PCNA, collagen I ↑ | Stimulated the AKT pathway to protect immortalized keratinocytes from heat-induced apoptosis | [65] | |
Stimulated the AKT pathway to protect immortalized keratinocytes from heat-induced apoptosis | ||||||
Human UC-MSCs | Exosomes | Akt, ERK, STAT3 | HGF, IGF1, NGF, SDF1↑ | Promoted the proliferation and migration of fibroblasts in normal and chronic wounds. This effect was positively correlated with the dose of exosomes | [66] | |
Induced pluripotent stem cell-derived MSCs | Exosomes | - | Collagen ↑ | Increased the secretion of collagen by HaCaT cells to accelerate skin cell proliferation | [67] | |
Adipose mesenchymal stem cells (ADSCs) | Exosomes | AKT/HIF-1α | - | Promoted the proliferation and migration of HaCaT cells by regulating the activation of the AKT/HIF-1α signaling pathway, thus promoting wound healing | [68] | |
Human UC-MSCs | Exosomes | - | PARP-1, PAR↑ | Suppressed HaCaT cell apoptosis induced by H2O2 by restraining the nuclear translocation of apoptosis-inducing factor (AIF) and promoting poly (ADP-ribose) (PAR) and poly ADP ribose polymerase 1 (PARP-1) expression | [69] | |
Human adipose-derived MSCs (adMSC-Exo) | Exosomes | miR-125a | Angiogenic inhibitor delta-like 4 (DLL4)↓ | Transferred miR-125a to endothelial cells and promoted angiogenesis by repressing DLL4 | [70] | |
Mouse BM- MSCs | Exosomes | miR-17 miR-23a miR-125b | TNF-α, IL-1β, iNOS, TLR4, IRAK1, p65↓ ARG1, IL-10, TGF-β↑ | Decreased the threshold for thermal and mechanical stimuli in mice | [71] | |
Increased nerve conduction velocity, the number of intraepidermal nerve fibers, myelin thickness, and axonal diameters | ||||||
Rat BM-MSCs | Exosomes | - | MDA, HIF1α, NOX2, Caspase 3, BAX, PARP1, MPO, ICAM1, IL-1β, NF-κB↓SOD, CAT, GPX, HO-1, BCL2, IL-10, bFGF, HGF, SOX9, VEGF↑ | Decreased histopathological score of kidney injury in rats | [72] | |
Reduced the levels of blood urea nitrogen (BUN) and creatinineReduced the level of oxidative stress | ||||||
Increased anti-oxidant status | ||||||
Reduced apoptosis and inflammation | ||||||
Improved regeneration and enhanced angiogenesis | ||||||
Human endometrial MSCs | Exosomes | - | Tie2, VEGF, Ang1, Ang2↑ | Increased the expression of angiogenesis markers, including Tie2, VEGF, Ang1, and Ang2, and increased the proliferation, migration, and angiogenesis of HUVECs | [73] | |
Human umbilical cord mesenchymal stem cells (hUCMSCs) | Exosomes | - | Ang2↑ | hucMSC-Ex-derived Ang-2 plays a significant role in tube formation of HUVECs and promotion of angiogenesis | [74] | |
Human UC blood-MSCs | Exosomes | - | Ang, Ang1, HFG, VEGF↑ | Human umbilical cord blood (UCB)-MSC-derived exosomes pretreated with thrombin could accelerate skin wound healing in rats with full-thickness wounds. Exosomes from human UCB-MSCs increased angiogenesis factors, such as VEGF, HGF, and Ang1, and decreased TNFα and IL-6 | [75] | |
Human UC-MSCs | Exosomes | Wnt4 | β-catenin, N-cadherin, PCNA, Cyclin D3↑ | Enhanced angiogenesis in rats through the Wnt4/β-catenin pathway. When the expression of Wnt4 was knocked out by shRNA, the proangiogenic effect of hUC-MSC-derived exosomes was eliminated | [76] | |
Human UC-MSCs | Exosomes | - | Increased the formation and maturation of new blood vessels at the wound site, although the mechanism is still unclear | [77] | ||
Human UC-MSCs | Exosomes | GSK3β-Wnt/β-catenin | - | Alleviated hepatic IRI by transporting miR-1246 via regulating GSK3β-mediated Wnt/β-catenin pathway | [78] | |
Remodeling Phase | Human gingival MSCs | Exosomes | - | Collagen↑ | Reduced the formation of scars by inhibiting the accumulation of mouse myofibroblasts | [79] |
Adipose mesenchymal stem cells (ASCs) | Exosomes | - | N-cadherin, cyclin-1, PCNA collagen I, III↑ | Facilitates cutaneous wound healing via optimizing the characteristics of fibroblasts | [62] | |
ASCs | Exosomes | ERK/MAPK | Matrix metalloproteinases-3 (MMP3)↑ | APromoted ECM reconstruction in cutaneous wound repair by regulating the ratios of collagen type III: type I, TGF-β3:TGF-β1, and MMP3:TIMP1, and by regulating fibroblast differentiation to mitigate scar formation | [63] | |
MenSCs | Exosomes | - | iNOS↓ ARG1, VEGF↑ | Resolved inflammation and ameliorated cutaneous non-healing wounds in diabetic mice | [49] | |
Induced M2 macrophage polarization |
- Citation: Zeng QL, Liu DW. Mesenchymal stem cell-derived exosomes: An emerging therapeutic strategy for normal and chronic wound healing. World J Clin Cases 2021; 9(22): 6218-6233
- URL: https://www.wjgnet.com/2307-8960/full/v9/i22/6218.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i22.6218